The therapy offers new hope in solid tumor treatment with fewer adverse effects.
The therapy offers new hope in solid tumor treatment with fewer adverse effects.
Pharmacies can adapt by embracing digital self-service options to better engage with patients, meet increasing consumer demand, and enhance revenue streams.
This article discusses clinical data for noncovalent Bruton tyrosine kinase inhibitors (BTKis), novel strategies in CLL, and the practical management of BTKi toxicities.
Pharmacists have developed an expanded role in the team-based approach through medication therapy management.
Meta-analysis of randomized controlled trials adds to growing evidence around certain antihypertensive drug classes showing promise for primary or secondary prevention of diabetes.
Artificial intelligence holds immense potential to address the rising demand for oncology services and improve patient outcomes by facilitating more effective, efficient, personalized cancer care.
AI is revolutionizing pharmacovigilance by enhancing data analysis, improving patient safety, and enabling proactive risk management in drug monitoring.
A panelist discusses how emerging chronic myeloid leukemia treatment advancements, including the addition of asciminib as a frontline tyrosine kinase inhibitor (TKI) option and ongoing research into dual TKI therapy and optimal dosing strategies, are expanding therapeutic choices while pharmacists play a key role in educating patients and providers about evolving treatment algorithms, evaluating new literature, and helping teams manage newer agents with less clinical experience.
As of now, data suggest minimal risk of drug interactions between oral contraceptives and injectable semaglutide.
Five crucial steps pharmacies can take to enhance patient engagement and lower operational costs.
Issues around patient safety, proper administration, and monitoring need careful consideration from pharmacists and other health care providers for vaccination efforts.
This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Real-world data can help resolve access barriers by providing a highly detailed view into the barriers that impact specific patient populations.
Environmental conditions and air pollution affect health by causing injuries and fatalities, exacerbating respiratory and cardiovascular diseases, and spreading infectious diseases.
By decade’s end, approval of additional bispecifics is expected for hematological malignancies, solid tumors, and non-oncology conditions such as inflammatory, autoimmune, neurodegenerative and vascular diseases, and ocular disorders and infections.
Accurate medication reconciliations are critical for ensuring safe patient outcomes, and a correct medication list can help prevent drug-drug interactions, contraindications, and duplicate therapies.
Paula E. Voinescu, PhD, MD, emphasized the need for additional research in this area, noting it is both “surprising and upsetting.”
Perhaps ashwagandha may aid in stress management, athletic performance, and sleep, but this effect is far from definitive.
Unique barriers can lead to psychiatric medication adherence rates as low as 26%.
Study shows that 98% of cases of multi-system inflammatory syndrome in children (MIS-C) were unvaccinated, suggesting that vaccination reduces the chance of a child who had COVID-19 later developing MIS-C.
Best practices call for referring to resources, such as those from HHS and the University of Liverpool.
The FDA reviews NDAs and BLAs to approve medications for sale and marketing in the US with decisions required by the PDUFA date.
Frequent reassessments of therapy regimens address polypharmacy, particularly for older patients.
Anxiety disorders create social and economic burdens as the availability of effective anxiolytic treatments are low.
Pharmacists and student pharmacists became the center of responding to the Monkeypox outbreak by providing immunizations to their communities.
Pharmaceutical companies must consider formulation, packaging, and labeling from the start to minimize errors and protect patients
In recent years, the auditing process has evolved into a full-blown investigation, often requiring pharmacies to submit hundreds of pages of documentation